Deep‐learning model to improve histological grading and predict upstaging of atypical ductal hyperplasia / ductal carcinoma in situ on breast biopsy
CY Huang, RF Chang, CY Lin, MS Hsieh… - …, 2024 - Wiley Online Library
Aims Risk stratification of atypical ductal hyperplasia (ADH) and ductal carcinoma in situ
(DCIS), diagnosed using breast biopsy, has great clinical significance. Clinical trials are …
(DCIS), diagnosed using breast biopsy, has great clinical significance. Clinical trials are …
Abstract P5-02-02: Artificial intelligence powered predictive analysis of atypical ductal hyperplasia from digitized pathology images
Abstract Background: Approximately 15-25% of patients with atypical ductal hyperplasia
(ADH) diagnosed on breast core needle biopsy (CNB) are upgraded to ductal carcinoma in …
(ADH) diagnosed on breast core needle biopsy (CNB) are upgraded to ductal carcinoma in …
Improving classification with forced labeling of other related classes: application to prediction of upstaged ductal carcinoma in situ using mammographic features
Predicting whether ductal carcinoma in situ (DCIS) identified at core biopsy contains occult
invasive disease is an import task since these “upstaged” cases will affect further treatment …
invasive disease is an import task since these “upstaged” cases will affect further treatment …
[HTML][HTML] Deep learning-based grading of ductal carcinoma in situ in breast histopathology images
Ductal carcinoma in situ (DCIS) is a non-invasive breast cancer that can progress into
invasive ductal carcinoma (IDC). Studies suggest DCIS is often overtreated since a …
invasive ductal carcinoma (IDC). Studies suggest DCIS is often overtreated since a …
A deep learning model for breast ductal carcinoma in situ classification in whole slide images
F Kanavati, S Ichihara, M Tsuneki - Virchows Archiv, 2022 - Springer
The pathological differential diagnosis between breast ductal carcinoma in situ (DCIS) and
invasive ductal carcinoma (IDC) is of pivotal importance for determining optimum cancer …
invasive ductal carcinoma (IDC) is of pivotal importance for determining optimum cancer …
[HTML][HTML] Ultrasound deep learning radiomics and clinical machine learning models to predict low nuclear grade, ER, PR, and HER2 receptor status in pure ductal …
M Zhu, Y Kuang, Z Jiang, J Liu, H Zhang, H Zhao… - Gland …, 2024 - ncbi.nlm.nih.gov
Background Low nuclear grade ductal carcinoma in situ (DCIS) patients can adopt proactive
management strategies to avoid unnecessary surgical resection. Different personalized …
management strategies to avoid unnecessary surgical resection. Different personalized …
Interobserver variability in ductal carcinoma in situ of the breast
MR Van Bockstal, M Berlière… - American journal of …, 2020 - academic.oup.com
Objectives Since most patients with ductal carcinoma in situ (DCIS) of the breast are treated
upon diagnosis, evidence on its natural progression to invasive carcinoma is limited. It is …
upon diagnosis, evidence on its natural progression to invasive carcinoma is limited. It is …
Prospective analysis using a novel CNN algorithm to distinguish atypical ductal hyperplasia from ductal carcinoma in situ in breast
S Mutasa, P Chang, J Nemer, EP Van Sant, M Sun… - Clinical breast …, 2020 - Elsevier
Introduction We previously developed a convolutional neural networks (CNN)-based
algorithm to distinguish atypical ductal hyperplasia (ADH) from ductal carcinoma in situ …
algorithm to distinguish atypical ductal hyperplasia (ADH) from ductal carcinoma in situ …
Computational pathology to discriminate benign from malignant intraductal proliferations of the breast
The categorization of intraductal proliferative lesions of the breast based on routine light
microscopic examination of histopathologic sections is in many cases challenging, even for …
microscopic examination of histopathologic sections is in many cases challenging, even for …
Sonography-based multimodal information platform for identifying the surgical pathology of ductal carcinoma in situ
H Wu, Y Jiang, H Tian, X Ye, C Cui, S Shi… - Computer Methods and …, 2024 - Elsevier
Background The risk of ductal carcinoma in situ (DCIS) identified by biopsy often increases
during surgery. Therefore, confirming the DCIS grade preoperatively is necessary for clinical …
during surgery. Therefore, confirming the DCIS grade preoperatively is necessary for clinical …